Facile Conversion of Cyclopropanols into Linear Conjugate Enones
(quint, J = 5.6 Hz, 1 H), 3.40 (dd, J = 9.4, 5.2 Hz, 1 H), 3.32 (dd,
J = 9.5, 6.2 Hz, 1 H), 2.94–2.89 (m, 2 H), 2.85–2.80 (m, 2 H), 2.54–
2.34 (m, 2 H), 0.92 (t, J = 7.9 Hz, 9 H), 0.57 (q, J = 7.8 Hz, 6
H) ppm. 13C NMR (100 MHz, CDCl3): δ = 199.2, 143.7, 141.3,
138.0, 132.5, 128.4, 128.3, 127.7, 126.0, 73.8, 73.3, 70.2, 41.4, 38.0,
+ Na]+. HRMS (ESI): m/z calcd. for C29H52O3Si2Na [M + Na]+
527.3347; found 527.3323.
Compound 4n: Colourless oil; [α]2D5 = –37.9 (c = 1.0, CHCl3). 1H
NMR (400 MHz, CDCl3): δ = 7.37–7.26 (m, 5 H), 6.88 (dt, J =
15.8, 7.5 Hz, 1 H), 6.25 (d, J = 15.6 Hz, 1 H), 4.53 (d, J = 12.3 Hz,
1 H), 4.49 (d, J = 12.5 Hz, 1 H), 3.95 (quint, J = 5.7 Hz, 1 H),
3.72–3.57 (m, 3 H), 3.42 (dd, J = 9.5, 5.5 Hz, 1 H), 3.37–3.33 (m,
4 H), 2.95–2.88 (m, 1 H), 2.54–2.34 (m, 2 H), 1.70–1.55 (m, 2 H),
1.10 (d, J = 7.1 Hz, 3 H), 0.89 (s, 9 H), 0.87 (s, 9 H), 0.04 (s, 6 H),
0.03 (s, 6 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 201.7, 143.4,
138.2, 131.6, 128.4, 127.61, 127.59, 79.4, 74.1, 73.4, 70.6, 59.5, 58.2,
47.8, 38.0, 35.6, 25.9, 25.8, 18.2, 18.1, 12.1, –4.5, –4.8, –5.3,
30.0, 6.8, 4.8 ppm. FTIR (film): ν = 3393, 3064, 3027, 2953, 2911,
˜
2875, 1601, 1496, 1455, 1413, 1365, 1237, 1096, 1006, 739,
697 cm–1. MS (ESI): m/z = 461.3 [M + Na]+. HRMS (ESI): m/z
calcd. for C27H38O3SiNa [M + Na]+ 461.2482; found 461.2484.
Compound 4j: Colourless oil; [α]2D7 = –7.4 (c = 1.0, CHCl3). 1H
NMR (400 MHz, CDCl3): δ = 7.38–7.26 (m, 5 H), 6.88 (dt, J =
15.8, 7.3 Hz, 1 H), 6.12 (d, J = 15.8 Hz, 1 H), 4.54 (d, J = 12.8 Hz,
1 H), 4.50 (d, J = 12.8 Hz, 1 H), 3.96 (quint, J = 5.5 Hz, 1 H), 3.42
(dd, J = 9.3, 5.3 Hz, 1 H), 3.38–3.26 (m, 5 H), 2.82 (t, J = 7.6 Hz,
2 H), 2.55–2.47 (m, 1 H), 2.43–2.35 (m, 1 H), 2.21 (t, J = 7.6 Hz,
2 H), 1.78 (s, 3 H), 0.88 (s, 9 H), 0.05 (s, 6 H) ppm. 13C NMR
(100 MHz, CDCl3): δ = 199.4, 143.7, 138.1, 132.5, 128.4, 127.63,
127.60, 74.0, 73.3, 70.4, 66.3, 40.1, 38.6, 38.0, 37.5, 32.9, 25.8, 18.1,
–5.4 ppm. FTIR (film): ν = 2954, 29219, 2896, 2856, 1693, 1667,
˜
1628, 1471, 1462, 1362, 1255, 1097, 1005, 836, 776, 734, 697 cm–1.
MS (ESI): m/z = 587.5 [M + Na]+. HRMS (ESI): m/z calcd. for
C31H56O5Si2Na [M + Na]+ 587.3559; found 587.3553.
Supporting Information (see footnote on the first page of this arti-
1
cle): Synthesis of the substrates, and copies of H, 13C NMR and
–4.5, –4.8 ppm. FTIR (film): ν = 3033, 2953, 2927, 2856, 1697,
˜
FTIR spectra for new compounds.
1672, 1632, 1453, 1362, 1254, 1099, 982, 836, 776, 736, 698 cm–1.
MS (ESI): m/z = 503.3 [M + Na]+. HRMS (ESI): m/z calcd. for
C25H40O3S2SiNa [M + Na]+ 503.2080; found 503.2103.
Acknowledgments
Compound 4k: Colourless oil; [α]2D8 = –35.4 (c = 1.0, CHCl3). 1H
NMR (400 MHz, CDCl3): δ = 6.95 (dd, J = 16.0, 6.8 Hz, 1 H),
6.16 (dd, J = 16.0, 1.2 Hz, 1 H), 3.98–3.91 (m, 4 H), 3.83 (quint, J
= 4.0 Hz, 1 H), 3.69–3.58 (m, 2 H), 2.91 (d, J = 13.8 Hz, 1 H), 2.87
(d, J = 13.6 Hz, 1 H), 2.56–2.48 (m, 1 H), 1.68–1.58 (m, 2 H), 1.55–
1.47 (m, 1 H), 1.43 (s, 3 H), 1.02 (d, J = 6.8 Hz, 3 H), 0.89 (s, 9
This work was supported by the National Basic Research Program
of China (973 Program, grant number 2010CB833200), the
National Natural Science Foundation of China (NSFC) (grant
numbers 21372248, 21172247, 21032002, and 20921091) and the
Chinese Academy of Sciences
H), 0.87 (s, 9 H), 0.05 (s, 3 H), 0.04 (s, 3 H), 0.03 (s, 6 H) ppm. 13
C
NMR (100 MHz, CDCl3): δ = 197.0, 150.6, 130.6, 108.2, 72.2, 64.6,
59.6, 49.2, 42.2, 36.5, 25.9, 25.8, 24.7, 18.2, 18.0, 14.1, –4.5, –4.6,
[1] For reviews, see: a) O. G. Kulinkovich, A. de Meijere, Chem.
Rev. 2000, 100, 2789–2834; b) I. Haym, M. A. Brimble, Org.
Biomol. Chem. 2012, 10, 7649–7665; c) A. Wolan, Y. Six, Tetra-
hedron 2010, 66, 15–61.
–5.3, –5.4 ppm. FTIR (film): ν = 2955, 2930, 2885, 2857, 1692,
˜
1663, 1623, 1472, 1463, 1380, 1361, 1255, 1095, 1047, 939, 836,
775 cm–1. MS (ESI): m/z = 509.4 [M + Na]+. HRMS (ESI): m/z
calcd. for C25H50O5Si2Na [M + Na]+ 509.3089; found 509.3103.
[2] See, for example: a) O. Kulinkovich, N. Masalov, V. Tyvorskii,
Tetrahedron Lett. 1996, 37, 1095–1096; b) A. L. Hurski, O. G.
Kulinkovich, Russ. J. Org. Chem. 2011, 47, 1653–1674; c) K.
Kim, J. K. Cha, Angew. Chem. Int. Ed. 2009, 48, 5334–5336;
Angew. Chem. 2009, 121, 5438; d) J. S. Kingsbury, E. J. Corey,
J. Am. Chem. Soc. 2005, 127, 13813–13815; e) A. Gollner, J.
Mulzer, Org. Lett. 2008, 10, 4701–4704; f) A. Gollner, K.-H.
Altmann, J. Gertsch, J. Mulzer, Chem. Eur. J. 2009, 15, 5979–
5997; g) H. Vnekatesan, M. C. Davic, Y. Altas, J. P. Snyder,
D. C. Liotta, J. Org. Chem. 2001, 66, 3653–3661; h) A. V. Brek-
ish, K. N. Prokhorevich, O. G. Kulinkovich, Eur. J. Org. Chem.
2006, 5069–5075; i) Z. Ye, T. Gao, G. Zhao, Tetrahedron 2011,
67, 5979–5989; j) D. Shklyaruck, E. Matiushenkov, Tetrahe-
dron: Asymmetry 2011, 22, 1448–1454; k) S. Baktharaman, S.
Selvakumar, V. K. Singh, Tetrahedron Lett. 2005, 46, 7527–
7529; l) S. E. Denmark, L. R. Marcin, J. Org. Chem. 1997, 62,
1675–1686; m) V. N. Odinokov, E. R. Shakurova, L. M. Khali-
lov, U. M. Dzhemilev, Russ. J. Org. Chem. 2009, 45, 1464–1467;
n) B. Achmatowicz, P. Jankowski, J. Wicha, Tetrahedron Lett.
1996, 37, 5589–5592; o) A. L. Hurski, N. A. Sokolov, O. G. Ku-
linkovich, Tetrahedron 2009, 65, 3518–3524; p) I. L. Lysenko,
A. V. Bekish, O. G. Kulinkovich, Russ. J. Org. Chem. 2002, 38,
875–879; q) V. N. Kovalenko, N. V. Masalov, O. G. Kulinkov-
ich, Russ. J. Org. Chem. 2009, 45, 1318–1324; r) A. V. Bekish,
K. N. Prokhorevich, O. G. Kulinkovich, Tetrahedron Lett.
2004, 45, 5253–5255; s) A. V. Bekish, V. E. Isakov, O. G. Kulin-
kovich, Tetrahedron Lett. 2005, 46, 6979–6981; t) I. L. Lysenko,
O. G. Kulinkovich, Russ. J. Org. Chem. 2005, 41, 70–74; u) I. V.
Mineyeva, O. G. Kulinkovich, Tetrahedron Lett. 2010, 51,
1836–1839.
Compound 4l: Colourless oil; [α]2D8 = –9.9 (c = 0.5, CHCl3). 1H
NMR (400 MHz, CDCl3): δ = 7.39–7.25 (m, 5 H), 6.95 (dd, J =
16.0, 7.4 Hz, 1 H), 6.16 (dd, J = 16.1, 1.0 Hz, 1 H), 3.72 (t, J =
5.2 Hz, 1 H), 3.72 (dd, J = 10.1, 5.6 Hz, 1 H), 3.69 (dd, J = 10.0,
7.0 Hz, 1 H), 3.05–3.00 (m, 2 H), 2.97–2.91 (m, 2 H), 2.67–2.58 (m,
1 H), 1.89 (quint, J = 6.3 Hz, 1 H), 1.12 (d, J = 6.8 Hz, 3 H), 0.98
(d, J = 6.8 Hz, 3 H), 0.97 (s, 9 H), 0.96 (s, 9 H), 0.13 (s, 3 H), 0.11
(s, 3 H), 0.10 (s, 3 H), 0.08 (s, 3 H) ppm. 13C NMR (100 MHz,
CDCl3): δ = 199.4, 151.4, 141.3, 129.2, 128.46, 128.35, 126.0, 76.5,
64.9, 41.7, 40.5, 40.4, 30.0, 26.0, 25.9, 18.31, 18.26, 14.4, 14.1, –4.0,
–4.1, –5.3, –5.4 ppm. FTIR (film): ν = 2956, 2929, 2881, 2857,
˜
1694, 1678, 1627, 1472, 1361, 1254, 1086, 1025, 836, 774, 698 cm–1.
MS (ESI): m/z = 527.4 [M + Na]+. HRMS (ESI): m/z calcd. for
C29H52O3Si2Na [M + Na]+ 527.3347; found 527.3328.
1
Compound 4m: Colourless oil; [α]2D7 = +28.3 (c = 0.5, CHCl3). H
NMR (400 MHz, CDCl3): δ = 7.30–7.16 (m, 5 H), 6.91 (dd, J =
16.2, 7.4 Hz, 1 H), 6.05 (d, J = 16.1 Hz, 1 H), 3.82 (dd, J = 6.3,
1.8 Hz, 1 H), 3.41 (t, J = 9.5 Hz, 1 H), 3.34 (dd, J = 9.8, 6.0 Hz, 1
H), 2.97–2.83 (m, 4 H), 2.58–2.49 (m, 1 H), 1.71–1.64 (m, 1 H),
1.04 (d, J = 6.8 Hz, 3 H), 0.91 (s, 9 H), 0.88 (s, 9 H), 0.75 (d, J =
6.8 Hz, 3 H), 0.06 (s, 3 H), 0.05 (s, 3 H), 0.03 (s, 3 H), 0.02 (s, 3
H) ppm. 13C NMR (100 MHz, CDCl3): δ = 199.6, 150.6, 141.3,
129.2, 128.5, 128.3, 126.0, 74.3, 65.6, 42.0, 41.4, 38.9, 30.1, 26.0,
25.9, 18.4, 18.2, 15.8, 10.8, –3.9, –4.3, –5.32, –5.36 ppm. FTIR
[3] a) K. A. Keaton, A. J. Phillips, Org. Lett. 2007, 9, 2717–2719;
b) K. A. Keaton, A. J. Phillips, Org. Lett. 2008, 10, 1083–1086;
c) J. McCabe, A. J. Phillips, Tetrahedron 2013, 69, 5710–5714.
(film): ν = 2956, 2928, 2856, 1698, 1679, 1627, 1471, 1361, 1252,
˜
1093, 1051, 836, 774, 698, 669 cm–1. MS (ESI): m/z = 527.4 [M
Eur. J. Org. Chem. 2014, 3841–3846
© 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
3845